Bellato, Rhael Vincent -.
HRN: 23-05-26 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/01/2023
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
06/01/2023
06/14/2023
IV
50mg
OD
PSNB
Waiting Final Action
Indication: ProphylaxisEmpiric Type of Infection: Bloodstream Compliance to guidelines: Guideline Not Available
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes